These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20644549)

  • 1. Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.
    Zhang ZT; Cao XB; Xiong N; Wang HC; Huang JS; Sun SG; Wang T
    Acta Pharmacol Sin; 2010 Aug; 31(8):900-6. PubMed ID: 20644549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K
    J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
    Joyce JN; Presgraves S; Renish L; Borwege S; Osredkar T; Hagner D; Replogle M; PazSoldan M; Millan MJ
    Exp Neurol; 2003 Nov; 184(1):393-407. PubMed ID: 14637109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
    Fonck C; Baudry M
    Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system.
    Guo H; Shi F; Li M; Liu Q; Yu B; Hu L
    BMC Complement Altern Med; 2015 May; 15():151. PubMed ID: 25994206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
    J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of total flavonoid fraction of the Epimedium koreanum Nakai extract on dopaminergic neurons: In vivo and in vitro.
    Wu L; Du ZR; Xu AL; Yan Z; Xiao HH; Wong MS; Yao XS; Chen WF
    Biomed Pharmacother; 2017 Jul; 91():656-663. PubMed ID: 28494419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
    Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
    J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.
    Yao L; Li W; She H; Dou J; Jia L; He Y; Yang Q; Zhu J; Cápiro NL; Walker DI; Pennell KD; Pang Y; Liu Y; Han Y; Mao Z
    J Biol Chem; 2012 Oct; 287(41):34246-55. PubMed ID: 22891246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Yokoyama H; Yano R; Kuroiwa H; Tsukada T; Uchida H; Kato H; Kasahara J; Araki T
    Metab Brain Dis; 2010 Jun; 25(2):135-43. PubMed ID: 20424905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice.
    Yokoyama H; Yano R; Kuroiwa H; Tsukada T; Uchida H; Kato H; Kasahara J; Araki T
    Metab Brain Dis; 2010 Sep; 25(3):305-13. PubMed ID: 20957419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.).
    Zhao G; Zheng XW; Qin GW; Gai Y; Jiang ZH; Guo LH
    Cell Mol Life Sci; 2009 May; 66(9):1617-29. PubMed ID: 19322517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin.
    Gao HL; Li C; Nabeka H; Shimokawa T; Saito S; Wang ZY; Cao YM; Matsuda S
    Neuroscience; 2013 Apr; 236():373-93. PubMed ID: 23321539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.
    Li DW; Yao M; Dong YH; Tang MN; Chen W; Li GR; Sun BQ
    Int J Mol Med; 2014 Nov; 34(5):1358-64. PubMed ID: 25174304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.